Document Detail

Lopinavir/ritonavir trough concentrations with the tablet formulation in HIV-1-infected women during the third trimester of pregnancy.
MedLine Citation:
PMID:  22263609     Owner:  NLM     Status:  Publisher    
Objectives: An observational, open-label study was performed to assess changes of lopinavir/ritonavir plasma concentrations during pregnancy. Methods: Adult HIV-1-infected women during the third trimester of pregnancy and on stable antiretroviral treatment including zidovudine/lamivudine plus lopinavir/ritonavir tablets (400/100 mg twice daily) were asked to participate. This group was compared with a group of non-pregnant HIV-1-infected women receiving the same antiretroviral regimen. The trough plasma concentration (C(trough)) of lopinavir and ritonavir was assessed at steady-state by a validated high-performance liquid chromatography (HPLC)-tandem mass spectrometry method. Results: A total of 41 HIV-positive female patients were enrolled in the study, with a median age of 28 y (range 20-37 y). These patients were stratified into 2 groups: 21 women in the third trimester of pregnancy (group A) and 20 non-pregnant women (group B). The geometric mean (95% confidence interval (CI)) plasma C(trough) of lopinavir was 4205 (2418-6896) ng/ml in group A and 5098 (3187-8084) ng/ml in group B. The reduction in lopinavir plasma levels observed in group A was not significant (geometric mean ratio 0.87, 95% CI 0.62-1.32; p = 0.411). No correlation was found between lopinavir plasma levels and adverse events (such as diarrhoea and hyperlipidaemia) or immunological parameters of HIV disease, and no changes in plasma HIV viral load were reported. Conclusion: In this study, a slight but not significant decrease in the plasma lopinavir C(trough) was found during the third trimester of pregnancy, suggesting that standard dosing of the tablet formulation is also appropriate during the later stages of pregnancy.
Leonardo Calza; Roberto Manfredi; Filippo Trapani; Caterina Salvadori; Vincenzo Colangeli; Marco Borderi; Gabriele Grossi; Roberto Motta; Pierluigi Viale
Related Documents :
21819579 - Preventing malaria in pregnancy through community-directed interventions: evidence from...
22169049 - Prescription drug use in pregnancy: a retrospective, population-based study in british ...
21703119 - Changes of nerve growth factor in amniotic fluid and correlation with ventriculomegaly.
21683219 - Tumor volume to fetal weight ratio as an early prognostic classification for fetal sacr...
23896029 - Treatment of pregnant spiny mice at mid gestation with a synthetic glucocorticoid has s...
6537789 - Kaolin-induced congenital hydrocephalus in utero in fetal lambs and rhesus monkeys.
20134189 - Inflammatory agents involved in septic miscarriage.
24392379 - Evaluation of anaemia in booked antenatal mothers during the last trimester.
7867579 - The fetal somatotropic axis during long term maternal undernutrition in sheep: evidence...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-1-21
Journal Detail:
Title:  Scandinavian journal of infectious diseases     Volume:  -     ISSN:  1651-1980     ISO Abbreviation:  -     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-1-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0215333     Medline TA:  Scand J Infect Dis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Internal Medicine, Geriatrics and Nephrologic Diseases, Section of Infectious Diseases.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Genetic variation in IL28B and treatment outcome in HBeAg-positive and -negative chronic hepatitis B...
Next Document:  Metal Organic Frameworks as Nitric Oxide Catalysts.